[Clinical studies of cefoperazone in the field of obstetrics and gynecology].
Clinical studies of cefoperazone (CPZ) were performed in 65 patients of obstetrics and gynecology, and the following results were obtained. When comparing the fever index of cases treated by CPZ to those by another prophylactic antibiotics, CPZ showed the lowest level comparable to CMX and LMOX. Clinical effects: The effectiveness of CPZ was 75% (excellent in 3 cases, good in 3 cases, poor in 2 cases) in 8 infectious cases. No side effects due to CPZ were noted.
Chimura
T
T
Morisaki
N
N
D001424:Bacterial Infections / Q000188:drug therapy*; D002438:Cefoperazone / Q000627:therapeutic use*; D002585:Cesarean Section; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007044:Hysterectomy; D010051:Ovarian Neoplasms / Q000601:surgery; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D013246:Sterilization, Tubal
D002438:Cefoperazone